[1]
“A Clinical Case of Successful Treatment of HER2-Low Disseminated Breast Cancer with Trastuzumab Deruxtecan”, Вопр. онкол., vol. 69, no. 4, pp. 757–760, Sep. 2023, doi: 10.37469/0507-3758-2023-69-4-757-760.